RA Capital Management, L.P. 13D and 13G filings for Enliven Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | ENLIVEN THERAPEUTICS INC ELVN | RA Capital Management, L.P. | 1,061,233 2.200% | -1,061,232 (-50.00%) | Filing |